POSTER: A Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification
T cell-mediated tumor death relies on complex mechanisms and cell-cell interactions, making the development of T cell-based therapies inherently challenging. Understanding T cell differentiation and function is critical for teasing apart the complexity of the tumor microenvironment, however, T cells are exceedingly heterogeneous in both phenotype and function and have variable responses to stimulation.
Download FileRelated Resources
View All ResourcesPRESENTATION: Accessing Broad B Cell Diversity to Rapidly Identify High-value Rabbit Monoclonal Antibodies
Opto® B Discovery on the Beacon® optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto® Memory B Discovery workflow, and share how customers are using the workflow to screen rabbit memory B cells to rapidly discover rabbit monoclonal antibodies (as presented at Antibody Engineering & Therapeutics 2023).
Datasheet: The Opto™ Antigen Presenting Bead Kit
Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.
BROCHURE: Beacon Select™ Optofluidic System | A4
- Approximately half the price of the 4-chip Beacon system
- A 2-chip automated optofluidic system, similar to the 4-chip Beacon® optofluidic system, which provides well-established workflows that have been adopted by ~130 customers
- Throughput scaled to meet the needs of small to mid-sized biopharma and CDMO/CRO companies